在接受依匹哌唑治疗的精神分裂症患者中，HTR2C-759C/T 多态性与体重增加无关。
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
机构信息
Vanda Pharmaceuticals Inc., Rockville, MD, USA.
出版信息
Psychiatry Res. 2010 Feb 28;175(3):271-3. doi: 10.1016/j.psychres.2009.03.020. Epub 2009 Dec 31.
Abstract
Weight gain is a common side effect of antipsychotics, contributing to poor treatment adherence, and previously linked to the -759C/T polymorphism near the serotonin receptor 2C gene. The effect of this polymorphism was analyzed in schizophrenia patients treated with iloperidone for up to 7 months. No association was detected with the modest weight changes observed in these patients.
摘要
体重增加是抗精神病药物的常见副作用，导致治疗依从性差，先前与位于血清素受体 2C 基因附近的 -759C/T 多态性有关。该多态性的作用在接受伊洛哌酮治疗长达 7 个月的精神分裂症患者中进行了分析。在这些患者中观察到的适度体重变化与该多态性无关。
Zotero 插件